Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (OTC Pink - No Information:OSIR)

During the Trading Day
4.74 +0.03 / +0.64%
As of 3:58pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.74 0.00 / 0.00%
Volume: --
Health Technology
Pharmaceuticals: Other

Company Description

Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Contact Information

Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia Maryland 21046-1707
P:(443) 545-1800
Investor Relations:



Mutual fund holders7.18%
Individual stakeholders45.08%
Other institutional1.83%

Top Executives

David A. DresnerPresident & Chief Executive Officer
Frank D. CzworkaChief Operating Officer
Gregory I. LawChief Financial Officer, Secretary & Treasurer
Alla DanilkovitchChief Scientific Officer
Philip R. JacobyChief Accounting Officer